| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | Nov 21, 2024 | Kairos Pharma, LTD. | CEO | Buy | 55.0 | +4,000 | 0.07% | ✗ | $5.8K |
| Sep 28, 2015 | Oct 1, 2015 | EOM Pharmaceutical Holdings, Inc. | Director | Sell | 27.5 | -14,674 | -41.93% | ✗ | $6.8K |
| Nov 25, 2013 | Nov 27, 2013 | EOM Pharmaceutical Holdings, Inc. | Secretary | Sell | 10.0 | -32,613 | -43.35% | ✓ | $92.9K |
| Oct 18, 2013 | Oct 22, 2013 | EOM Pharmaceutical Holdings, Inc. | Secretary | Sell | 7.5 | -267,387 | -93.04% | ✓ | $778.3K |